FDA Drug Shortages
Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Start Over | Back to Previous Screen
Piperacillin and Tazobactam (Zosyn) Injection
Status: Currently in Shortage
»Date first posted:
04/02/2014
»Therapeutic Categories: Anti-Infective; Pediatric
Apollo Pharmaceuticals Inc. (New 04/21/2017)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 3.375 gm/vial (Carton of 10) (NDC 39822-0125-4) | Available | Available under X-GEN Pharmaceuticals, Inc. To order, contact X-GEN Pharmaceuticals, Inc. Customer Service/Order Entry at 1-866-390-4411. | Other |
| 2.25 gm/vial (10 Vials) (NDC 39822-0123-2) | Available | Available under X-GEN Pharmaceuticals, Inc. To order, contact X-GEN Pharmaceuticals, Inc. Customer Service/Order Entry at 1-866-390-4411. | Other |
| 4.5 gm/vial (10 Vials) (NDC 39822-0127-6) | Available | Available under X-GEN Pharmaceuticals, Inc. To order, contact X-GEN Pharmaceuticals, Inc. Customer Service/Order Entry at 1-866-390-4411. | Other |
| 40.5 gm/vial (NDC 39822-0139-7) | Available the first week of May 2017 | Other |
Apotex Corp. (Reverified 07/11/2018)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2.25 gm/vial (10 Vials) (NDC 60505-0686-4) | Currently unavailable and temporarily discontinued due to requirements related to complying with good manufacturing practices | Demand increase in the drug | |
| 3.375 gm/vial (10 Vials)(NDC 60505-0687-4) | Currently unavailable and temporarily discontinued due to requirements related to complying with good manufacturing practices | Demand increase in the drug | |
| 4.5 gm/vial (10 Vials) (NDC 60505-0688-4) | Currently unavailable and temporarily discontinued due to requirements related to complying with good manufacturing practices | Demand increase in the drug | |
| 40.5 gm/vial (NDC 60505-0773-4) | Currently unavailable and temporarily discontinued due to requirements related to complying with good manufacturing practices | Demand increase in the drug |
AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.) (Reverified 03/12/2018)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2.25 g SDV Cartons of 10 (NDC 55150-119-30) | Available | Check wholesalers for inventory | Other |
| 3.375 g SDV Cartons of 10 (NDC 55150-120-30) | Available | Check wholesalers for inventory | Other |
| 4.5 g SDV Cartons of 10 (NDC 55150-121-50) | Available | Check wholesalers for inventory | Other |
Fresenius Kabi USA, LLC (Reverified 06/26/2018)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2.25 g, single-dose vial (NDC 63323-309-20) | Available | Check wholesalers for inventory. | Demand increase for the drug |
| 3.375 g, single-dose vial (NDC 63323-300-30) | Available | Check wholesalers for inventory. | Demand increase for the drug |
| 4.5 g, single-dose vial (NDC 63323-320-50) | Available | Check wholesalers for inventory. | Demand increase for the drug |
| 40.5 g, PBP (NDC 63323-304-74) | Available | Check wholesalers for inventory. | Demand increase for the drug |
Hospira, Inc. (Revised 07/20/2018)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2.25 g; Single Dose ADD-Vantage Vial (NDC 00409-3374-02) | Available | Other | |
| 3.375 g; Single Dose ADD-Vantage Vial (NDC 00409-3378-13) | Limited Supply Available. Next Delivery and Estimated Recovery: July 2018 | Demand increase for the drug | |
| 4.5 g; Single Dose ADD-Vantage Vial (NDC 00409-3379-04) | Limited Supply Available. Next Delivery: August 2018; Estimated Recovery: September 2018 | Demand increase for the drug | |
| 2.25 g; Single Dose Glass Fliptop Vial (NDC 00409-3383-02) | Available | Other | |
| 3.375 g; Single Dose Glass Fliptop Vial (NDC 00409-3385-13) | Available | Other | |
| 4.5 g; Single Dose Glass Fliptop Vial (NDC 00409-3390-04) | Available | Other | |
| 13.5 g; Pharmacy Bulk Vial (NDC 00409-2999-14) | Available | Other |
Mylan Institutional (Reverified 07/16/2018)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2.25 g Pkg of 10 (NDC 67457-521-22) | Available | Demand increase for the drug | |
| 3.375 g Pkg of 10 (NDC 67457-522-37) | Available | Demand increase for the drug | |
| 4.5 g Pkg of 10 (NDC 67457-523-45) | Available | Demand increase for the drug |
Pfizer Pharmaceuticals (Reverified 07/20/2018)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Zosyn; 2.25 g/50 mL; Frozen Galaxy Bag (NDC 00206-8860-02) | Limited Supply Available | Check Wholesaler and Distributors for Availability | Other |
| Zosyn; 3.375 g/50 mL; Frozen Galaxy Bag (NDC 00206-8861-02) | Limited Supply Available | Check Wholesaler and Distributors for Availability | Other |
| Zosyn; 4.5 g/100 mL; Frozen Galaxy Bag (NDC 00206-8862-02) | Limited Supply Available | Check Wholesaler and Distributors for Availability | Other |
| Zosyn 2.25g 10's (NDC 0206-8852-16) | Next Delivery and Estimated Recovery: TBD | Shortage per manufacturer: Manufacturing Delay | Other |
| Zosyn; 3.375 g; Single Use Vial (NDC 00206-8854-16) | Next Delivery and Estimated Recovery: TBD | Shortage per Manufacturer: Manufacturing Delay | Other |
| Zosyn; 4.5 g; Single Use Vial (NDC 00206-8855-16) | Next Delivery and Estimated Recovery: TBD | Shortage per Manufacturer: Manufacturing Delay | Other |
| Zosyn; 40.5 g; Pharmacy Bulk Vial (NDC 00206-8859-10) | Next Delivery and Estimated Recovery: TBD | Shortage per Manufacturer: Manufacturing Delay | Other |
Sagent Pharmaceuticals (Reverified 07/19/2018)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2.25mg 30mL vial, (NDC 25021-164-30) | Available | Demand increase for the drug | |
| 3.375g 30mL vial, (NDC 25021-165-30) | Available | Demand increase for the drug | |
| 4.5g 48mL vial, (NDC 25021-166-48) | Available | Demand increase for the drug |
Sandoz (Reverified 07/16/2018)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2.25g (NDC 0781-3344-95) | Limited supply estimated until August 2018. Once depleted, will be permanently discontinued. | Other | |
| 4.5g (NDC 00781-3114-95) | Not on backorder | Other | |
| 3.375g (NDC 00781-3113-95) | Not on backorder | Other | |
| 2.25g (NDC 00781-3110-95) | Supply disruption letter sent out. Temporarily unavailable | Other | |
| 3.375g (NDC 00781-9350-95) | Permantly discontinued | Other | |
| 3.375g (NDC 00781-3350-95) | Permantly discontinued | Other | |
| 4.5g (NDC 00781-3367-95) | Permantly discontinued | Other | |
| 4.5g (NDC 00781-9367-95) | Limited supply estimated until August 2018. Once depleted, will be permanently discontinued. | Other | |
| 2.25g (NDC 00781-9344-95) | Permanently discontinued | Other |
WG Critical Care (Reverified 04/27/2018)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2.25g (NDC 44567-0801-10) | Available | Product continues to be manufactured, please check wholesalers for inventory. | Increased demand for the product. |
| 3.375g (NDC 44567-0802-10) | Available | Product continues to be manufactured, please check wholesalers for inventory. | Increased demand for the product. |
| 4.5g (NDC 44567-0803-10) | Available | Product continues to be manufactured, please check wholesalers for inventory. | Increased demand for the product. |
| 40.5g (NDC 44567-0804-01) | Available | Product continues to be manufactured, please check wholesalers for inventory. | Increased demand for the product. |
Wockhardt (Reverified 07/11/2018)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2.25 g/vial, 10 vials (NDC 64679-034-01) | Available | ||
| 3.375 g/vial, 10 vials (NDC 64679-056-01) | Available | ||
| 4.5 g/vial, 10 vials (NDC 64679-012-01) | Available | ||
| 40.5 g/vial, 1 vial (NDC 64679-679-01) | Available |
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English